Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $526.07 ($5.1M) on 2026-10-14, disclosed to the SEC on 2026-10-15.
Scheduled sale ($5.1M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $526.07 | 40 | $21K | 0.4% |
| 2 | $530.09 | 160 | $85K | 1.7% |
| 3 | $531.19 | 120 | $64K | 1.2% |
| 4 | $532.48 | 40 | $21K | 0.4% |
| 5 | $534.63 | 240 | $128K | 2.5% |
| 6 | $535.89 | 400 |
| $214K |
| 4.2% |
| 7 | $537.19 | 633 | $340K | 6.6% |
| 8 | $538.00 | 1,127 | $606K | 11.8% |
| 9 | $539.09 | 525 | $283K | 5.5% |
| 10 | $540.23 | 2,002 | $1.1M | 21.1% |
| 11 | $541.20 | 1,930 | $1.0M | 20.4% |
| 12 | $542.07 | 883 | $479K | 9.3% |
| 13 | $543.15 | 400 | $217K | 4.2% |
| 14 | $544.35 | 480 | $261K | 5.1% |
| 15 | $545.48 | 480 | $262K | 5.1% |
| 16 | $546.00 | 40 | $22K | 0.4% |
| Total | $539.99 avg | 9,500 | $5.1M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-09 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-08 | $5.2M | — | Filing → |